Intensity Modulated Radiation Therapy — CPB 0590 | AETNA Coverage Update

Aetna, a CVS Health company, modified CPB 0590 covering intensity modulated radiation therapy (IMRT), effective December 4, 2025. Here's what billing teams need to do.

Aetna updated its IMRT coverage policy under CPB 0590 in the Aetna system, confirming medical necessity coverage for IMRT planning, delivery, image guidance, and fiducial marker placement across nine CPT codes and six HCPCS codes. The codes directly affected include 77301, 77385, 77386, 77387, 77338, 32553, 49327, 49411, 49412, A4648, C1739, C9728, G6015, G6016, and G6017. If your practice bills for radiation oncology services under Aetna, this policy update touches nearly every line item in your IMRT charge capture.

Quick-Reference Table

Aetna IMRT Coverage Criteria and Medical Necessity Requirements 2025

The core medical necessity standard under this Aetna IMRT coverage policy hasn't shifted dramatically — but the details matter. Aetna covers IMRT when critical structures cannot be adequately protected using standard 3-dimensional conformal radiotherapy. That's the threshold your clinical documentation must clear.

The real issue here is that Aetna delegates the specific clinical criteria to eviCore Healthcare's Radiation Therapy Clinical Guidelines. Aetna does not publish the full list of covered indications in CPB 0590 itself. You need to pull the current eviCore guidelines directly from eviCore's provider portal to know exactly what diagnoses and clinical scenarios qualify for CPT 77385 or 77386 reimbursement.

This matters more than it sounds. eviCore can update its guidelines at any time — not just annually. Aetna's policy explicitly states that eviCore "reserves the right to change and update the guidelines without prior notice." Draft guidelines are posted 90 days before implementation, but interim changes can happen without that buffer. Your billing team should monitor eviCore's site, not just Aetna's.

Prior authorization through eviCore is effectively required for IMRT services under this policy. Aetna routes radiation oncology prior auth through eviCore, so claim denial risk is highest when the IMRT indication doesn't match eviCore's current clinical criteria. Check the criteria at the time of authorization, not at the time of billing — they can change between those two points.

Fiducial marker placement — billed under CPT 32553, 49327, 49411, or 49412 — carries its own medical necessity criteria. Three conditions must all be true: the IMRT medical necessity criteria must be met, the radiation target must not be clearly visible, and bony anatomy must be insufficient for adequate target alignment. All three. Document each one explicitly in the clinical record before billing any of the marker placement codes.

Image guidance coverage — for inter-fraction and intra-fraction systems — is confirmed under CPT 77387 and HCPCS G6017. This includes named systems like the Calypso 4D Localization System and the RayPilot System. Coverage here is tied to the delivery of IMRT or other conformal radiotherapy, so image guidance billed independently from a covered IMRT course will likely generate a claim denial.

Coverage Indications at a Glance

Aetna IMRT Billing Guidelines and Action Items 2025

These are the steps your billing and revenue cycle teams should take now — before the December 4, 2025 effective date passes without action.

CPT, HCPCS, and ICD-10 Codes for IMRT Under CPB 0590

Covered CPT Codes (When Selection Criteria Are Met)

Covered HCPCS Codes (When Selection Criteria Are Met)

Key ICD-10-CM Diagnosis Codes

The ICD-10 range here is broad by design. Aetna's coverage policy covers IMRT across the full neoplasms chapter. Your clinical documentation still needs to support the specific IMRT indication per eviCore's guidelines — the ICD-10 code alone won't satisfy medical necessity review.

The Bigger Picture on CPB 0590

The structure of this policy is what deserves your attention as much as the content. Aetna effectively outsources the clinical criteria to eviCore, then tells you in the same policy that eviCore can change those criteria without warning. That's a meaningful compliance gap for any practice doing high-volume IMRT billing.

This is a different situation than a standard coverage policy update with fixed criteria and a stable effective date. Your prior auth process, your documentation templates, and your claim denial management all need to account for criteria that can shift mid-year. Build that monitoring into your revenue cycle workflow now — not after the first denial.

If your payer mix includes a significant share of Aetna commercial lives and you're billing complex IMRT with CPT 77386 regularly, the financial exposure here is real. A single denied IMRT course is a large claim. A pattern of denials because your team missed an eviCore guideline update is a revenue cycle problem.